Category: combination
SL.TLF.0714.SW.FE.TM
SL.TLF.0714.SW.FE.TM Nombre moyen d’heures travaillées chez les enfants, études et emploi, filles,
View DetailsYONDELIS 0,25 MG PERF FL (Trabectedine)
YONDELIS 0,25 MG PERF FL (Trabectedine) - Médicament désigné comme "orphelin" *Treatment of patie
View DetailsYONDELIS 1 MG PERF FL (Trabectedine)
YONDELIS 1 MG PERF FL (Trabectedine) - Médicament désigné comme "orphelin" *Treatment of patients
View DetailsROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab)
ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatment
View DetailsTHYROGEN 0,9 MG INJ FL (Thirotropine)
THYROGEN 0,9 MG INJ FL (Thirotropine) - Maladie rare sans désignation orpheline * For use with se
View DetailsVELCADE 1 MG INJ FL (Bortezomib)
VELCADE 1 MG INJ FL (Bortezomib) - Maladie rare sans désignation orpheline * As monotherapy or in
View DetailsVELCADE 3,5 MG INJ FL 1 (Bortezomib)
VELCADE 3,5 MG INJ FL 1 (Bortezomib) - Maladie rare sans désignation orpheline * As monotherapy o
View DetailsORENCIA 125 MG INJ SRG 1 ML + P/A (Abatacept)
ORENCIA 125 MG INJ SRG 1 ML + P/A (Abatacept) - Maladie rare sans désignation orpheline In combin
View DetailsORENCIA 250 MG PERF FL + SRG (Abatacept)
ORENCIA 250 MG PERF FL + SRG (Abatacept) - Maladie rare sans désignation orpheline In combination
View Details